Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
12.37
+1.08 (9.57%)
At close: Nov 9, 2026, 4:00 PM EST
12.42
+0.05 (0.40%)
Pre-market: Nov 10, 2026, 7:01 AM EST

Ginkgo Bioworks Holdings Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-251.03-312.76-547.03-892.87-2,105-1,830
Depreciation & Amortization
33.7540.2945.0254.8142.5529.08
Other Amortization
18.718.71815.7--
Loss (Gain) From Sale of Assets
--7.8643.34-28.8-
Asset Writedown & Restructuring Costs
--78.27130.591.16-
Loss (Gain) From Sale of Investments
14.8513.0228.8354.8353.3411.54
Loss (Gain) on Equity Investments
6.68--2.6443.7677.28
Stock-Based Compensation
61.4481.55112.34229.881,9311,606
Other Operating Activities
5.6132.2426.7935.75-152.92-86.16
Change in Accounts Receivable
2.05-1.47-4.7350.0755.02-114.09
Change in Accounts Payable
-34.74-2.994.77-1.18-10.84-2.25
Change in Unearned Revenue
-19.39-32.39-68.65-35.92-36.42-10.5
Change in Other Net Operating Assets
-14.38-7.23-21.0716.87-44.7765.3
Operating Cash Flow
-166.99-171.06-319.59-295.5-252.2-253.82
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-6.56-7.67-62.54-40.8-52.27-56.52
Sale of Property, Plant & Equipment
0.570.570.654.43--
Cash Acquisitions
---5.4-74.73-12.04
Divestitures
----42.98-55.72-
Investment in Securities
111.15-233.254.52--3.69-5
Other Investing Activities
0.050.050.54-1.34-30.440.3
Investing Cash Flow
105.22-240.29-62.24-80.69-67.39-73.26

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--0.35-0.9-1.3-1.24-1.12
Net Debt Issued (Repaid)
-0.04-0.35-0.9-1.3-1.24-1.12
Issuance of Common Stock
32.9519.470.080.0999.542,485
Repurchase of Common Stock
----0.02-0.98-901.71
Other Financing Activities
-1.79-1.34-0.93-1.99-1.99-48.19
Financing Cash Flow
31.1217.78-1.74-3.2295.341,534

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.230.2-0.28-0.590.91-0.02
Net Cash Flow
-30.88-393.37-383.84-380-223.351,207

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-173.54-178.72-382.13-336.3-304.47-310.34
Free Cash Flow Growth
------
Free Cash Flow Margin
-132.73%-105.04%-168.31%-133.74%-63.74%-98.89%
Free Cash Flow Per Share
-2.86-3.22-7.36-6.92-7.25-9.13
Levered Free Cash Flow
-90.59-72.88-238.01-119.75596.72444.82
Unlevered Free Cash Flow
-90.59-72.88-237.96-119.69596.78446.31

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
000.030.080.092.37
Cash Income Tax Paid
0.190.190.890.67-0.06
Change in Working Capital
-66.46-44.09-89.6729.84-37.01-61.54
SEC Filings: 10-K · 10-Q